Epidermal Growth Factor (EGF) receptor overexpression, KRAS, TP53, CDKN2A and SMAD4 mutations characterize pancreatic ductal adenocarcinoma. The gene discussed is KRAS; the disease is pancreatic ductal adenocarcinoma.